Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

The association of cardioprotective medications with pneumonia-related outcomes

Wu, A and Good, C and Downs, JR and Fine, MJ and Pugh, MJV and Anzueto, A and Mortensen, EM (2014) The association of cardioprotective medications with pneumonia-related outcomes. PLoS ONE, 9 (1).

[img]
Preview
PDF
Published Version
Available under License : See the attached license file.

Download (439kB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)

Abstract

Introduction: Little research has examined whether cardiovascular medications, other than statins, are associated with improved outcomes after pneumonia. Our aim was to examine the association between the use of beta-blockers, statins, angiotensin converting enzyme (ACE) inhibitors, and angiotensin II receptor blockers (ARBs) with pneumonia-related outcomes. Materials and Methods: We conducted a retrospective population-based study on male patients ≥65 years of age hospitalized with pneumonia and who did not have pre-existing cardiac disease. Our primary analyses were multilevel regression models that examined the association between cardiovascular medication classes and either mortality or cardiovascular events. Results: Our cohort included 21,985 patients: 22% died within 90 days of admission, and 22% had a cardiac event within 90 days. The cardiovascular medications studied that were associated with decreased 90-day mortality included: statins (OR 0.70, 95% CI 0.63-0.77), ACE inhibitors (OR 0.82, 95% CI 0.74-0.91), and ARBs (OR 0.58, 95% CI 0.44-0.77). However, none of the medications were significantly associated with decreased cardiovascular events. Discussion: While statins, ACE inhibitors, and ARBs, were associated with decreased mortality, there was no significant association with decreased CV events. These results indicate that this decreased mortality is unlikely due to their potential cardioprotective effects.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Wu, A
Good, Ccbg15@pitt.eduCBG15
Downs, JR
Fine, MJmjf1@pitt.eduMJF1
Pugh, MJV
Anzueto, A
Mortensen, EM
Contributors:
ContributionContributors NameEmailPitt UsernameORCID
EditorGong, YanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Date: 28 January 2014
Date Type: Publication
Journal or Publication Title: PLoS ONE
Volume: 9
Number: 1
DOI or Unique Handle: 10.1371/journal.pone.0085797
Schools and Programs: School of Medicine > Medicine
Refereed: Yes
Date Deposited: 17 Jun 2014 14:57
Last Modified: 13 Oct 2017 20:55
URI: http://d-scholarship.pitt.edu/id/eprint/21890

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com


Actions (login required)

View Item View Item